These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 16616877
1. Dynamic changes of apoptosis-inducing ligands and Th1/Th2 like subpopulations in Hantaan virus-induced hemorrhagic fever with renal syndrome. Liu JM, Zhu Y, Xu ZW, Ouyang WM, Wang JP, Liu XS, Cao YX, Li Q, Fang L, Zhuang R, Yang AG, Jin BQ. Clin Immunol; 2006 Jun; 119(3):245-51. PubMed ID: 16616877 [Abstract] [Full Text] [Related]
2. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Rus V, Zernetkina V, Puliaev R, Cudrici C, Mathai S, Via CS. Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346 [Abstract] [Full Text] [Related]
3. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes]. Wu LY, Li X, Chang CK, Ying SX, Pu Q. Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133 [Abstract] [Full Text] [Related]
4. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL. Jabłońska E, Kiersnowska-Rogowska B, Rogowski F, Parfieńczyk A, Puzewska W, Bukin M. Rocz Akad Med Bialymst; 2005 Aug; 50():204-7. PubMed ID: 16358967 [Abstract] [Full Text] [Related]
5. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J. J Am Coll Cardiol; 2005 Apr 05; 45(7):1018-24. PubMed ID: 15808757 [Abstract] [Full Text] [Related]
6. T cells and eosinophils in bronchial smooth muscle cell death in asthma. Solarewicz-Madejek K, Basinski TM, Crameri R, Akdis M, Akkaya A, Blaser K, Rabe KF, Akdis CA, Jutel M. Clin Exp Allergy; 2009 Jun 05; 39(6):845-55. PubMed ID: 19400895 [Abstract] [Full Text] [Related]
7. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Nomura S, Ishii K, Inami N, Uoshima N, Ishida H, Yoshihara T, Kitayama H, Hayashi K. Transpl Immunol; 2007 Nov 05; 18(2):115-21. PubMed ID: 18005854 [Abstract] [Full Text] [Related]
8. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection. Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G. J Clin Virol; 2005 Sep 05; 34(1):63-70. PubMed ID: 16087126 [Abstract] [Full Text] [Related]
9. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts. Grzasko N, Dmoszynska A, Hus M, Soroka-Wojtaszko M. Haematologica; 2006 Mar 05; 91(3):386-9. PubMed ID: 16531263 [Abstract] [Full Text] [Related]
10. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? Herbeuval JP, Shearer GM. AIDS Rev; 2006 Mar 05; 8(1):3-8. PubMed ID: 16736946 [Abstract] [Full Text] [Related]
11. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M. Ann Rheum Dis; 2005 Jun 05; 64(6):854-8. PubMed ID: 15564310 [Abstract] [Full Text] [Related]
12. [Involvement of TRAIL up-regulation of CD4+, CD8+ T cells in liver injury in chronic hepatitis B]. Chen GY, He JQ, Lv GC, Li MW, Xu CH, Fan WW, Chen Z. Zhonghua Gan Zang Bing Za Zhi; 2004 May 05; 12(5):284-6. PubMed ID: 15161504 [Abstract] [Full Text] [Related]
13. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura. Liu F, Wu C, Yang X, Xiao H, Zhuo X, Cheng Z, Chen Q. Cell Mol Immunol; 2005 Oct 05; 2(5):387-92. PubMed ID: 16368066 [Abstract] [Full Text] [Related]
14. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma. Tian JQ, Wang ZP, Rodriguez R, Fu JS, Lu JZ, Ma BL. Urology; 2006 May 05; 67(5):1093-8. PubMed ID: 16635513 [Abstract] [Full Text] [Related]
15. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, Iwamoto K, Ohtani H, Sawada K. Nephrol Dial Transplant; 2005 Mar 05; 20(3):539-44. PubMed ID: 15671071 [Abstract] [Full Text] [Related]
16. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Clin Immunol; 2006 Sep 05; 120(3):297-309. PubMed ID: 16784892 [Abstract] [Full Text] [Related]
17. [A clinical study on CD178 positive T lymphocyte in hemorrhagic fever with renal syndrome]. Gai ZT, Zhang Y, Dong GF, Zu YH, Zhang Y, Wu SY. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec 05; 19(4):383-6. PubMed ID: 16416001 [Abstract] [Full Text] [Related]
18. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Cell Immunol; 2006 Feb 05; 239(2):121-8. PubMed ID: 16808908 [Abstract] [Full Text] [Related]
19. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis. Bühling F, Wille A, Röcken C, Wiesner O, Baier A, Meinecke I, Welte T, Pap T. Respir Res; 2005 Apr 17; 6(1):37. PubMed ID: 15833141 [Abstract] [Full Text] [Related]
20. [Application of flow microbeads assay in detection of specific antibodies and cytokines in serum from patients with hemorrhagic fever with renal syndrome]. Zhang J, Lin Y, Jin BQ. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar 17; 25(3):245-7. PubMed ID: 19257990 [Abstract] [Full Text] [Related] Page: [Next] [New Search]